(Q48003979)

7 February 2018

title

Human HER-2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for 'self' tumour antigens. (English)

1 reference

7 February 2018

0 references

M L Disis

1

1 reference

7 February 2018

F M Shiota

series ordinal

2

1 reference

7 February 2018

M A Cheever

series ordinal

3

1 reference

7 February 2018

publication date

1 February 1998

1 reference

7 February 2018

published in

Immunology

1 reference

7 February 2018

volume

93

1 reference

7 February 2018

page(s)

192-199

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

Cancer antigens: immune recognition of self and altered self

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

Induction of anti-self-immunity to cure cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

Oncogenic proteins as tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

The cellular immune response to immunization with zona pellucida antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

The inability to process a self-peptide allows autoreactive T cells to escape tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00424.X

Prevention of breast tumour development in vivo by downregulation of the p185neu receptor

21 January 2018

1 reference

12 December 2020

Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein.

1 reference

12 December 2020

HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer.

1 reference

12 December 2020

Antibody to ras proteins in patients with colon cancer.

1 reference

12 December 2020

Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2

1 reference

12 December 2020

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer

1 reference

12 December 2020

Circulating antibodies against c-myc oncogene product in sera of colorectal cancer patients

1 reference

12 December 2020

p185neu expression in human lung adenocarcinomas predicts shortened survival

1 reference

12 December 2020

Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer

1 reference

12 December 2020

Breaking T cell tolerance with foreign and self co-immunogens. A study of autoimmune B and T cell epitopes of cytochrome c

1 reference

12 December 2020

The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot

1 reference

12 December 2020

Characterization of antigenicity and immunogenicity patterns of native and recombinant zona pellucida proteins in the white-tailed deer (Oidocoileus virginianus)

1 reference

12 December 2020

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

12 December 2020

10.1046/J.1365-2567.1998.00424.X

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

9616368

1 reference

7 February 2018